Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: Leuk Lymphoma. 2020 Mar 9;61(7):1627–1635. doi: 10.1080/10428194.2020.1728748

Table III:

Estimated mean difference in cognitive test scores (and 95% confidence intervals).

Model 1a Model 2a Model 3a, b
Higher-risk vs. Lower-risk Treated vs. Treatment Naïve Higher-risk vs. Lower-risk Treated vs. Treatment Naïve
Direction Of Better Score β (95%CI) β (95%CI) β (95%CI) β (95%CI)
NIH-TB Total Composite Scorec (primary outcome) Higher −1.96 (−4.94,1.01) −0.38 (−3.53,2.77) −1.96 (−4.99,1.07) −0.03 (−3.22,3.16)
 Dimensional Change Card Sort Higher −2.05 (−5.34,1.23) −0.58 (−4.06,2.90) −2.01 (−5.36,1.33) −0.22 (−3.74,3.31)
 Oral Reading Recognition Higher −3.22 (−6.78,0.34)* 0.82 (−2.97,4.61) −3.45 (−7.08,0.17)* 1.44 (−2.37,5.26)
 Picture Vocabulary Test Higher −2.20 (−4.76,0.36)* −0.41 (−3.13,2.31) −2.19 (−4.80,0.41)* −0.01 (−2.76,2.73)
 Flanker Inhibitory Control & Attention Higher −0.17 (−2.46,2.13) −0.81 (−3.23,1.61) −0.04 (−2.37,2.30) −0.80 (−3.26,1.66)
 List Sorting Working Memory Higher 0.41 (−2.46,3.27) −0.48 (−3.50,2.54) 0.50 (−2.42,3.42) −0.57 (−3.64,2.50)
 Pattern Comparison Higher 0.35 (−3.49,4.19) −0.80 (−4.84,3.24) 0.50 (−3.41,4.41) −0.89 (−5.01,3.23)
 Picture Sequence Matching Higher 0.66 (−2.68,4.01) −0.69 (−4.21,2.83) 0.80 (−2.61,4.20) −0.83 (−4.42,2.75)
HVLT-R Total Correct Immediate Recall Higher -1.81 (−3.29,−0.32)e −0.44 (−2.04,1.15) -1.79 (−3.30,−0.28)e −0.14 (−1.73,1.45)
HVLT-R Total Correct Delayed Recall Higher −0.38 (−1.19,0.44) −0.10 (−0.96,0.76) −0.37 (−1.20,0.46) −0.04 (−0.91,0.84)
TMT-A time in secondsd Lower 6.89 (0.24,13.54)e 3.46 (−3.59,10.51) 6.54 (−0.20,13.28)* 2.43 (−4.63,9.50)
TMT-B time in secondsd Lower 15.41 (3.32,27.51)e 2.69 (−10.26,15.65) 15.37 (3.10,27.65)e 0.28 (−12.59,13.15)
COWA total correct words Higher 0.21 (−0.96,1.38) 0.66 (−0.57,1.89) 0.11 (−1.07,1.30) 0.64 (−0.61,1.89)
FACT-Cog Higher −0.08 (−3.96,3.80) -6.12 (−10.07,−2.17)f 0.84 (−2.98,4.66) -6.26 (−10.27,2.25)f

NIH-TB: National Institutes of Health Toolbox Cognition Battery; FACT-Cog: Functional Assessment After Cancer Treatment Cognition; COWA: Controlled Word Association Test; HVLT-R: Hopkins Verbal Learning Test Revised; TMT-A/B: Trail Making Test A or B.

Boldindicates statistical significance p<0.05,

*

indicates p<0.10, prior to adjustment for multiple comparisons. False discovery rate adjusted p-values are available in Supplemental Table 1.

a

Model adjusted for age, gender, race, and education,

b

model mutually assessed both treatment and risk status,

c

fully adjusted NIH toolbox scores are t –scores,

d

these models had three potential influential outliers, estimates upon removal: TMT-A Model 1 β =4.16 95%CI −0.21 to 8.52; TMT-B Model 1 β =11.63 95%CI 2.82 to 20.45; TMT-A Model 3 β =4.07 95%CI −0.37 to 8.52; TMT-B Model 3 β =13.20 95%CI 1.70 to 24.69,

e

after adjustment for multiple comparisons trends remained (P<0.2) but were no longer significant,

f

after adjustment for multiple comparisons effect remains significant (p=0.030).